New Changes in SAC Capital’s 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other

In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves: reductions in the ownership of Annies Inc (NYSE:BNNY) and American Woodmark Corporation (NASDAQ:AMWD), an increase in the holding of Silicon Motion Technology Corp. (ADR) (NASDAQ:SIMO) and a new position - Cytokinetics, Inc. (NASDAQ:CYTK).

Steven Cohen

Cohen has reduced his fund’s stake in Annies Inc (NYSE:BNNY) to 890,400 shares or 5.2% of the total number of shares outstanding. Ken Griffin, on the other hand, is bullish on this stock, having increased his fund’s stake by 900% in the Q4 of 2013. The company engages in the production and distribution of natural and organic food products. It has a market cap of $647 million and does not pay a dividend. The stock is traded at a Price to Earnings (P/E) ratio of 45.xx, almost three times the industry average of 15.40. The stock has been in a downtrend since October 2013 and has depreciated by approximately 12% so far this year to a current price of $37.94 per share.

Another reduction, albeit a small one, is American Woodmark Corporation (NASDAQ:AMWD). SAC has slightly reduced its position to 1.04 million shares, which account for 6.7% of the company’s common stock. Chuck Royce, the manager of Royce & Associates, also slightly reduced his fund stake to approximately 594,400 shares valued at $23.5 million. The company has recently announced its financial performance for the three months ending January 31, 2014: $169 million in revenues and earnings of $0.18 per share. Analysts expect the company to post revenues of $187 million and earnings per share (EPS) of $0.4 for the current quarter.

Silicon Motion Technology Corp. (ADR) (NASDAQ:SIMO) ended up on the Cohen’s buy list, with SAC Capital reporting an increase by almost 500,000 shares of its position, taking it to 1.69 million shares or 5.2% of the company’s common stock. D. E. Shaw is also bullish and has increased his fund’s stake by 39% during the last quarter of 2013. The company has a market cap of $553 million and pays an annual dividend of $0.6, yielding 3.5%. The stock is traded at a trailing P/E ratio of 21.xx, which is pretty much inline with the industry average of 20.00. For the three months ending December 31, 2013, Silicon Motion Technology posted revenues of $52.5 million and EPS of $0.16.

Steven Cohen has recently started a new position in Cytokinetics, Inc. (NASDAQ:CYTK). Together with SAC Capital, Cohen holds a little over 2 million shares, which account for 5.5% of the total number of shares outstanding. Jim Simmons seems to share Cohen’s outlook for this company, having himself initiated a new position. This biopharmaceutical company has a market cap of $344 million and does not pay a dividend. So far this year, the stock has advanced 47% to a current price of $9.55 per share. Cytokinetics announced revenues of $24.3 million and earnings of $0.22 per share for the 2013 fourth quarter. 2014 first quarter is expected to bring revenues of $7.69 million and a loss per share of $0.35.

Disclosure: none.

Recommended reading:

SAC Capital’s Latest Portfolio Moves: Zynga Inc (ZNGA), Tessera Technologies, Inc. (TSRA) And Others

Second Wave of Moves from SAC Capital

Recent Changes in SAC Capital Advisors’ Equity Portfolio

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!